US20140051914A1 - Gastric bypass band and surgical method - Google Patents

Gastric bypass band and surgical method Download PDF

Info

Publication number
US20140051914A1
US20140051914A1 US13/767,354 US201313767354A US2014051914A1 US 20140051914 A1 US20140051914 A1 US 20140051914A1 US 201313767354 A US201313767354 A US 201313767354A US 2014051914 A1 US2014051914 A1 US 2014051914A1
Authority
US
United States
Prior art keywords
latch
expansion
band device
band
resistant section
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/767,354
Inventor
Mathias Asongwe Lawrence FOBI
C. Bruce Fields
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bariatec Corp
Original Assignee
Bariatec Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bariatec Corp filed Critical Bariatec Corp
Priority to US13/767,354 priority Critical patent/US20140051914A1/en
Publication of US20140051914A1 publication Critical patent/US20140051914A1/en
Priority to US15/170,831 priority patent/US20170020705A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/005Gastric bands
    • A61F5/0066Closing devices for gastric bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12009Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
    • A61B19/54
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/005Gastric bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3966Radiopaque markers visible in an X-ray image

Definitions

  • the present invention pertains to devices for performing gastric bypass surgery for morbidly obese individuals, and more specifically, to a gastric bypass band which creates a small gastric pouch from the esophagus and a portion of the proximal stomach.
  • This invention also details the gastric bypass surgery method that is performed in conjunction with the application of the gastric bypass band.
  • Morbidly obese individuals are identified as those where the disease of obesity has advanced to where the individual has a Body Mass Index (BM1) of over 40 or a BMI of over 35 along with other “co-morbidities” such as diabetes or high blood pressure.
  • BM1 Body Mass Index
  • BMI Body Mass Index
  • a 5-foot-10-inch man or a 5-foot-4-inch woman would need to weigh 243 pounds and 204 pounds, respectively.
  • dieting has often become a futile effort, as while some pounds may be shed, over time it has been found that these pounds are often quickly regained.
  • Due to the health threats posed by their condition morbidly obese individuals have turned to gastric bypass surgery in increasing numbers as an effective method to lose weight.
  • U.S. Pat. No. 5,771,903 issued to Jakobsson involves a method of gastric bypass surgery where the lower part of the esophagus is dissected and a band is applied around the lower part of the esophagus and an upper part of the stomach to form a small gastric pouch which upon filling with minimal food gives the patient a feeling of fullness or satiety.
  • the band is inflatable and serves as a type of restrictor valve to regulate the amount of food passing from the banded upper gastric pouch to the unrestricted lower stomach.
  • the band can be selectively inflated or deflated, depending upon the amount of food that is desired to be passed from the upper to lower stomach.
  • U.S. Pat. No. 6,572,627 issued to Gabbay discloses a system to inhibit the expansion of the stomach.
  • the system involves placing a band about midway along the patient's stomach to create a restricted, smaller stomach.
  • the system also employs a section of webbing that is placed around the upper half of the now restricted stomach. The webbing helps limit the expansion of the upper stomach.
  • Other inflatable band devices include the Lap BandTM System from Inamed Health of Santa Barbara, Calif.; the HeliogastTM gastric band from Helioscopie of Vienne Cedex, France; the MidbandTM from Medical Innovation Development of Villeurbanne, France; and the Swedish Adjustable Gastric Band (SAGB) from Ethicon Endo-Surgery of the United States. These devices are placed around the stomach at its top or midpoint to create a smaller stomach.
  • SAGB Swedish Adjustable Gastric Band
  • the Proring® and Siliband® are gastric bands, both from Innovative Obesity Care of Saint Etienne, France, which require that the top of the stomach and esophagus first be stapled to form a small stomach pouch.
  • the Proring® and Siliband® are then placed at the bottom of the pouch to form a restrictor valve for regulating the passage of food materials into the lower stomach.
  • the Proring® has a closeable latch with a male-female engagement which is locked by the placement of a suture.
  • the Siliband is closed and attached with sutures.
  • the adjustable band devices can have a cross sectional contact width as large as 1′′ which has been found to cause the leakage of pouch contents into the peritoneal cavity, should these devices erode into the gastric pouch.
  • the body is unable to form scar tissue around, and seal off, such a wide band device. This erosion problem is serious in that some deaths have occurred, and in lesser cases, these prior art bands have had to be removed, or else additional surgeries were necessary to repair leakage problems.
  • the adjustable band devices have a tendency to accidentally enlarge, thereby letting more food through the restricted area than desired, and causing weight gain to return.
  • the invention is a method for performing gastric bypass surgery and an inventive gastric bypass band used along with the method.
  • the method of surgery involves separating the esophagus and a portion of the proximal stomach from the top of the remaining major portion of the stomach.
  • the separated portion is used to form a small gastric pouch that can hold between 20-30 cc (about 1 ⁇ 8 cup) of food material.
  • the inventive gastric bypass band is then placed in the mid-portion of the pouch to create a valve-like opening which will cause solid foods to stay in the gastric pouch for awhile, to give the sensation of a “full stomach.”
  • the band also prevents stomal dilation, that is the stoma, or opening between the pouch and small intestine (described further below) is prevented from dilating.
  • the small intestine is bisected to create a top section and a bottom section.
  • the top section includes the duodenum which retains all of its capability to receive liver bile, enzymes, and pancreatic secretions.
  • the bottom section is connected to the bottom of the gastric pouch so that any food materials that pass by the gastric band restriction will empty directly into the small intestine for further digestion.
  • the top section is then connected to the bottom section of the intestine which allows liver bile and pancreatic secretions from the top section to come into contact with the partially digested food materials that have been traveling from the gastric pouch down to the bottom section.
  • Liver bile begins fat digestion for the first time and as a result, fats are only partially absorbed, contributing to greater weight loss.
  • the majority portion of the stomach comprising the remaining stomach and duodenum is completely separated from the manufactured digestive tract consisting of the gastric pouch and bottom section of the small intestine.
  • the majority portion is sewed against the inner body cavity wall of the patient, and a radiopaque marker band is placed between the majority portion and the body cavity wall.
  • a gastrostomy tube is placed through the marker band for immediate post operative care and the radiopaque marker band functions as a marker to locate this stomach site if it becomes necessary to place a gastrostomy tube for decompression or to feed the patient normally through the stomach or else to allow the surgery to be reversed and the stomach reconnected at a later date.
  • the inventive gastric bypass band is also radiopaque.
  • the gastric band device which also comprises the invention is comprised of an expansion-resistant section that is attached to a latching mechanism.
  • the latching mechanism is of a one-way, male-female design, which comes together from opposite ends of the expansion-resistant section.
  • the band device assumes a radial shape which encircles the gastric pouch at a location selected by the surgeon.
  • the radial shape and small width of the band helps prevent the device from becoming ingrown into the gastric pouch and/or causing tissue necrosis.
  • the radial shape is best achieved if the opposite components of the latch are curved to aid in forming the radial shape upon joining the ends of the latch together.
  • An object of the invention is to provide a gastric bypass surgical method which bypasses the majority of the stomach and duodenum, thereby resulting in less post-surgery expansion of the gastric pouch.
  • Another object of the invention is to provide a gastric bypass band device which is available in multiple sizings to be able to meet any surgical situation.
  • Still another object of the invention is to provide a medical method and associated gastric band device which results in maintaining a 90% weight loss, beyond 5 years post-surgery, in morbidly obese patients.
  • Another object of the invention is to provide a device that can be easily placed and removed less invasively, laparoscopically, thereby reducing surgical recovery time to around three weeks.
  • FIG. 1 is a frontal view of a human esophagus, stomach and partial small intestine to illustrate the body locations near the esophagus and small intestine where the inventive medical procedure is performed.
  • FIG. 2 is a frontal view of a human body cavity showing the esophagus connected to the lower portion of the small intestine and the upper portion of the small intestine, containing the duodenum, being connected to the lower portion of the small intestine.
  • FIG. 3 is an elevated perspective view of the inventive gastric bypass band shown in its engaged state.
  • FIG. 4 is a cross sectional view through the expansion resistant section of the inventive gastric bypass band.
  • FIG. 5A is a closeup elevated perspective view of the female portion of the latch.
  • FIG. 5B is a closeup elevated perspective view of the male portion of the latch.
  • FIG. 5C is a closeup elevated perspective view of the male portion of the latch fully engaged within the female portion.
  • FIG. 6 is a side view of the gastric bypass band device shown in an engaged position, illustrating the radial shape of the device.
  • FIG. 7A is a side view of a protective cover for engaging with the female portion of the gastric bypass band device.
  • FIG. 7B is a front elevated perspective view of the cover.
  • FIG. 8 is an elevated perspective view of the radiopaque marker band of the present invention.
  • FIGS. 1 and 2 the preferred embodiment of the inventive medical method can be shown.
  • the medical method is performed laparoscopically in 90% of the cases.
  • FIG. 1 the organs of the esophagus 10 , stomach 14 , duodenum 16 , small intestine 18 and gall bladder 20 are shown.
  • the focus of the medical method is upon the modifications made to the esophagus 10 , stomach 14 and small intestine 18 .
  • a gastric pouch is manufactured by preferably separating the esophagus 10 and part of the lesser curvature 22 of the stomach from the remainder of the stomach 14 at point A.
  • the small intestine 18 is bisected at point B.
  • point B is preferred because it results in the duodenum 16 being completely bypassed along with the stomach 14 . Bypassing the duodenum results in selective fat malabsorption which results in more weight loss than in prior art gastric bypass methods.
  • the duodenum remains fully functional and continues to receive liver bile from the hepatic ducts 24 and enzymes from the pancreatic duct 26 .
  • the proximal stomach is bisected on the lesser curvature 22 just below the esophagus 10 , leaving a small stomach segment 28 that is connected to the proximal jejunum 18 , this esophogeal and small stomach segment is what will eventually form the gastric pouch 30 having a size of between 20-30 cc.
  • the bottom section of the small intestine (proximal jejunum) 18 below the duodenum 16 is connected to the small stomach segment 28 through a hand sewn closure to form an anastomosis (not shown) that is 1.5 to 2 cm wide.
  • the anastomosis is impervious to air and water and allows direct entry of the contents of the gastric pouch 30 into the small intestine 18 , which causes the release of satiety stimulating chemicals known as enterokinins.
  • enterokinins satiety stimulating chemicals known as enterokinins.
  • This release of enterokinins is even induced by the obese individual's salivary secretions that go from the gastric pouch 30 to the small intestine 18 .
  • This feeling of satiety, or “fullness” results in anorexia and enhances initial weight loss as well as the maintenance of weight loss over time.
  • the inventive gastric bypass band device 32 Above the anastomosis and above the bottom of the pouch 30 , about 2 cm, is placed the inventive gastric bypass band device 32 .
  • the gastric band device acts as a restrictor valve which controls the emptying of partially digested food materials from the gastric pouch 30 .
  • the gastric band 32 is preferably placed at the distal portion of the gastric pouch 30 .
  • the portion of the pouch above the gastric band is 15 to 20 cc in capacity and the portion of the pouch below the band is about 8 to 10 cc in capacity. This compared to the normal 2000-3000 cc capacity of the stomach illustrates the restriction in food intake provided by the gastric pouch.
  • the gastric band device 32 preferably ranges in size between 5.5-7.0 cm in inner circumference. In addition to its function as a restrictor valve, the gastric band 32 prevents stomach dilation, meaning that the restricted opening provided by the band never expands in size due to the expansion-resistant construction of the device. Moreover, the pouch 30 is more resistant to expansion than the stomach. The relative size of the pouch ensures that excessive expansion does not occur. Patients that have been X-rayed five years post-surgery show that the pouch has not expanded by much.
  • the small size of the pouch insures that if a patient over-eats, the food will back up into the esophagus, thereby causing the patient to regurgitate the food. This factor operates as a self-regulating feature, and for this reason, patients are counseled to keep their food intake to a minimum.
  • the duodenum 16 is re-joined to the small intestine 18 to form a Y-limb 34 , with one deviation of the limb going upward to the duodenum and the other deviation proceeding upward to the gastric pouch 30 .
  • the intestine-intestine connection 36 forms an anastomosis (not shown) of approximately 2 cm, that is wide enough to allow food to pass through easily.
  • pancreatic juices and liver bile from the duodenum can now come into contact with the partially digested food that travels down the second section of the intestine from the pouch.
  • Liver bile begins fat digestion for the first time, and as a result, fats are only partially absorbed, thereby helping contribute to weight loss.
  • the stomach 14 although disconnected, remains fully functional, and if necessary can be reactivated by reversing the surgery and re-connecting the stomach segment 28 and small intestine 18 to their prior, natural, state.
  • the stomach 14 can also be reactivated by placing a temporary gastrostomy tube 38 , as shown, through which food can be routed, should this be necessary.
  • the stomach opening 40 can be marked with a radiopaque marker band 42 or disk, that is sutured to the abdominal wall, thereby making it clearly visible to allow the surgeon to find the stomach entry site 40 on an X-ray, to allow easy reactivation.
  • the gastric bypass band 32 is comprised of an expansion-resistant section 44 mated to a latch 46 , which locks upon full engagement, thereby preventing the device 32 from opening up while positioned within the body.
  • the latch 46 is of a one-way variety and can only be released through the application of a specialized surgical tool (not shown).
  • the expansion-resistant section 44 prevents the device from expanding too far, thereby restricting the amount of food traveling from the gastric pouch 30 to the small intestine 18 .
  • the expansion-resistant section 44 is preferably made from implant grade silicone rubber surrounding a monofilament core.
  • the monofilament can be polypropylene suture material, which is resistant to expansion.
  • the latch is preferably made from surgical-grade plastics such as polypropylene or acetal, which gives both strength and lubricity to the latch.
  • FIG. 4 shows a transverse cross section of the expansion-resistant section 44 which illustrates the monofilament core 48 surrounded by silicone material 50 .
  • the silicone material can be a silicone tube having a monofilament core therein.
  • the expansion-resistant section 44 preferably has a flat-faced inner side 52 as shown. This flat face 52 continues longitudinally along the length of the expansion-resistant section 44 .
  • the flat face 52 forms a flat-sided inner circumference when the latch of the device is engaged, as shown in FIG. 3 . It has been found that the flat face prevents the expansion-resistant section from migrating into the patient's tissue and prevents tissue erosion.
  • the cross-sectional diameter of the expansion-resistant section 44 is kept to 0.125′′, or less. If erosion occurs, it has been found that if the cross section is kept to these approximate dimensions the pouch tissue will form a scar around the band device 32 , and in essence seal off the device, thereby preventing any leakage.
  • Erosion is caused by tissue necrosis, where tissue dies when the supply of blood to the area is cut off.
  • Prior art larger, thicker, band devices have been known to necrose when the food pouch begins to sag, making a deep sack out of which food has difficulty being passed. This food begins to decay in the pouch, which can lead to necrotic complications.
  • the larger, thicker, prior art devices penetrate the necrosed area in time, creating a break in the gastric pouch, which can lead to leakage of the pouch contents into the interior of the body cavity. In the worst cases this can lead to death; in the minor cases, additional surgery is necessary to repair the breached pouch. Contrastingly, fewer pouch breaches are experienced with the present invention than with the prior art devices.
  • the latch 46 can be examined.
  • the latch is preferably a one-way latch employing a one-way male-female engagement.
  • the opposite ends 54 , 56 of the expansion-resistant section 44 are each mated to one-half of the male-female latch as shown in FIG. 3 and a preferred method of mating is further described below.
  • the female portion 58 of the latch 46 is illustrated in detail.
  • the female portion has an exterior body 60 and an interior lumen 62 for receiving the male portion 64 of the latch.
  • the lumen 62 is sized to compress the lateral prongs 66 of the male portion 64 .
  • a pair of openings 68 are placed in each side 70 of the female portion 58 to allow for the expansion of the lateral catches 72 of the male portion. 64 .
  • the lateral catches 72 engage fully and laterally within the side openings 68 , in a one-way fashion.
  • Side openings 68 have top, bottom, rear and front walls, which engage catches 72 .
  • the engagement is such that the latch can be released only after applying a special surgical tool (not shown) to disengage the latch 46 , by placing inward force upon catches 72 through side openings 68 .
  • the lumen 62 opens outward and the face 74 of the opening of the lumen is inwardly beveled so as to receive the outward bevels 76 of the male portion 64 .
  • the corner facings 78 of the female portion 58 are rounded so as to present a non-irritating surface to the patient.
  • the body 60 of the female portion 58 is longitudinally curved 80 .
  • the curvature of the female portion 58 mates with the longitudinally curved male portion 64 to form the device 32 into a radial shape as shown in FIG. 6 .
  • This radial shape is crucial for preventing the device from becoming ingrown within a patient's tissue, as this shape applies equal pressure to the enclosed tissue at every point along the inside circumference of the device 32 .
  • Shapes that are non-circular tend to apply unequal pressure along their inside circumference, thereby resulting in a cutoff of blood supply, necrosis, and eventual tissue erosion and leakage as discussed previously.
  • a corresponding radius of curvature applies which contributes to the forming of the proper radial shape in each case.
  • the inner circumference that is used is open to the discretion of the surgeon, but generally, men require 6.5 and 7.0 cm sizes while women require 5.5 and 6.0 cm devices.
  • the male portion of the latch is shown as comprising a pair of lateral prongs 66 , the prongs being longitudinally curved to mate efficiently within the lumen 62 of the female portion 58 .
  • prongs 66 are approximately 0.076′′ thick, by 0.040′′ wide.
  • the prongs terminate at their front with lateral catches 72 which are molded integrally with the prongs 66 .
  • Lateral catches 72 are angled longitudinally along their side face 84 , the angled attitude allowing easy entry of the prongs 66 into the lumen 62 of the female portion 58 , which is an important feature under surgical conditions.
  • Side faces 84 having steeper angles give a mechanical advantage when locking.
  • the preferred angle of side faces is 36 degrees or less.
  • the catches 72 further comprise lateral catch faces 86 , which engage the front walls of the side openings 68 of the female portion 58 . When the catches 72 of prongs engage, it is preferred that they remain engaged under a pulling stress of at least 5 pounds of force.
  • the prongs 66 are separated by inner space 88 , which allows the prongs to travel inward and outward.
  • the prongs 66 terminate rearwardly at prong body 90 , which provides a base of structural integrity from which prongs can confidently travel inward and outward as they engage the interior walls of lumen.
  • Prong body 90 migrates further rearward to become outwardly beveled face 76 which mates with inwardly beveled face 74 of the female portion 58 .
  • the beveled face 76 migrates further rearward to become hilt 92 .
  • Hilt 92 is where the front opening of the female portion 58 fully engages against. This engagement is shown in FIG. 5C which illustrates lateral catches 72 seated in the side openings 68 of female portion 58 , the hilt being 92 engaged with the front opening of female portion.
  • the circumference of the body 60 of female portion 58 and the circumference of the hilt 92 of the male portion 64 are preferably identical so as to provide a fairly uninterrupted surface traveling from one to the other.
  • anchor arms 94 which are used to attach the male and female portions of latch to the expansion-resistant section 44 .
  • Anchor arms 94 retain the curved theme of the male and female portions, 58 , 64 of the latch 46 .
  • Anchor arms 94 are molded integrally with their corresponding latch portion and curve rearwardly so as to retain the radii of curvature of the inventive device noted previously.
  • the expansion-resistant section which is comprised of surgical grade silicone and monofilament is attached to the anchor arms as follows. Referring again to FIG. 5B , the front opening 96 of lumen 98 is shown, and its rearward path of travel through anchor arm is shown in phantom. A similar arrangement exists for female portion.
  • Monofilament 48 enters the rear of anchor arm and is fed through lumen until it protrudes through the front opening of lumen. The monofilament 48 is then tied off in a manner so as to anchor it in place along with the silicone material as seen in phantom, in FIG. 3 .
  • the body 60 of female portion 58 may also be fitted with a disposable cover 100 so as to reduce its potential to snag upon tissue as it is being fed through and positioned around the gastric pouch 30 during laparoscopic surgery. As the device is fed through the tissue and around the new pouch, it is led by the female portion 58 .
  • Cover 100 provides a streamlined shape which can be grasped by a forceps and easily led through the tissue.
  • FIG. 7A is a side view showing the female end 58 positioned in the cover 100 , with the remainder of the device trailing out the back end 102 of cover 100 .
  • Back end 102 of cover includes a lumen (see FIG.
  • cover 100 further comprises a blunt front end 108 which extends into an elongate portion 110 .
  • the blunt front end 108 facilitates easy movement through tissue.
  • the elongate portion 110 is for grasping by the surgeon's forceps to allow the cover to be threaded through tissue.
  • the cover 100 has a gently tapered region 112 , which, again contributes to easy movement through tissue. At its widest point, the cover is about 0.250 to allow easy movement through a trocar during laparoscopic surgery.
  • the cover is preferably made from a radiopaque material for easy sighting on an X-ray. The cover is removed and discarded once the device has been positioned around the gastric pouch.
  • the radiopaque marker band 42 previously shown in FIG. 2 can be more precisely described.
  • the band's inside diameter is approximately 0.8′′ and the outside diameter is approximately 1′′ with a thickness of approximately 0.06′′.
  • the band is preferably flat along its major surfaces 114 , 116 .
  • the marker band 42 can be made from polyester mesh that is coated with surgical grade silicone.
  • the inventive device 32 can be combined with the radiopaque marker band 42 shown in FIG. 8 , as well as with the disposable cover 100 to form a surgical kit. This kit can then be installed surgically using the method previously described.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nursing (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pathology (AREA)
  • Reproductive Health (AREA)
  • Surgical Instruments (AREA)
  • Bag Frames (AREA)

Abstract

The present invention relates to a nano-enhanced device for substance transfer between the device and a tissue. The device comprises a substrate with substantially aligned carbon nanotubes anchored within the substrate, and with at least one end of the carbon nanotubes protruding from the substrate. The protruding nanotube ends may be coated with a drug for delivery of the drug into body tissue. The present invention may be incorporated into an angioplasty catheter balloon or into a patch that is worn on the skin. The carbon nanotubes can be grouped in clusters to effectively form nano-needles which can transfer fluid to or from the subdermal tissue. The nano-needles can be used in conjunction with a sensor to ascertain body fluid information such as pH, glucose level, etc.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 13/053,018 filed Mar. 21, 2011, which is a continuation of U.S. application Ser. No. 10/876,397 filed Jun. 24, 2004, now U.S. Pat. No. 7,909,839, which claims the benefit of U.S. Provisional Ser. No. 60/574,741 filed on May 26, 2004, which applications are fully incorporated herein by reference.
  • FIELD OF INVENTION
  • The present invention pertains to devices for performing gastric bypass surgery for morbidly obese individuals, and more specifically, to a gastric bypass band which creates a small gastric pouch from the esophagus and a portion of the proximal stomach. This invention also details the gastric bypass surgery method that is performed in conjunction with the application of the gastric bypass band.
  • BACKGROUND
  • In the United States, obesity affects the health of 80 million adults, or 35 per cent of the adult population, according to statistics from the Centers for Disease Control and Prevention. American children are also becoming increasingly affected by obesity, as 9 million, or 15 per cent of the child population has fallen victim to this disease in recent years.
  • Morbidly obese individuals are identified as those where the disease of obesity has advanced to where the individual has a Body Mass Index (BM1) of over 40 or a BMI of over 35 along with other “co-morbidities” such as diabetes or high blood pressure. To reach a BMI of 35, a 5-foot-10-inch man or a 5-foot-4-inch woman would need to weigh 243 pounds and 204 pounds, respectively. For these individuals, dieting has often become a futile effort, as while some pounds may be shed, over time it has been found that these pounds are often quickly regained. Due to the health threats posed by their condition, morbidly obese individuals have turned to gastric bypass surgery in increasing numbers as an effective method to lose weight.
  • There are a number of methods of gastric bypass surgery, as well as a number of medical appliances which have been developed to assist in the application of these methods. However, most methods of gastric bypass surgery operate on the theme of creating a reduced-size “gastric” pouch” out of the stomach, which remains connected to the small intestine. The pouch restricts the amount of food entering the body to a fraction of what would normally enter an unrestricted stomach. Once the pouch is full, the patient often experiences the same feelings of fullness and satiety as would be experienced with an unrestricted stomach.
  • U.S. Pat. No. 5,771,903 issued to Jakobsson involves a method of gastric bypass surgery where the lower part of the esophagus is dissected and a band is applied around the lower part of the esophagus and an upper part of the stomach to form a small gastric pouch which upon filling with minimal food gives the patient a feeling of fullness or satiety. The band is inflatable and serves as a type of restrictor valve to regulate the amount of food passing from the banded upper gastric pouch to the unrestricted lower stomach. The band can be selectively inflated or deflated, depending upon the amount of food that is desired to be passed from the upper to lower stomach.
  • U.S. Pat. No. 6,572,627 issued to Gabbay discloses a system to inhibit the expansion of the stomach. The system involves placing a band about midway along the patient's stomach to create a restricted, smaller stomach. The system also employs a section of webbing that is placed around the upper half of the now restricted stomach. The webbing helps limit the expansion of the upper stomach.
  • Other inflatable band devices include the Lap Band™ System from Inamed Health of Santa Barbara, Calif.; the Heliogast™ gastric band from Helioscopie of Vienne Cedex, France; the Midband™ from Medical Innovation Development of Villeurbanne, France; and the Swedish Adjustable Gastric Band (SAGB) from Ethicon Endo-Surgery of the United States. These devices are placed around the stomach at its top or midpoint to create a smaller stomach.
  • The Proring® and Siliband® are gastric bands, both from Innovative Obesity Care of Saint Etienne, France, which require that the top of the stomach and esophagus first be stapled to form a small stomach pouch. The Proring® and Siliband® are then placed at the bottom of the pouch to form a restrictor valve for regulating the passage of food materials into the lower stomach. The Proring® has a closeable latch with a male-female engagement which is locked by the placement of a suture. The Siliband is closed and attached with sutures.
  • The prior art gastric band devices and their associated medical procedures have a success rate of about 65%, with many patients experiencing weight gain again after 5 years. Also, the following complications can result from existing devices and procedures.
  • First, the adjustable band devices can have a cross sectional contact width as large as 1″ which has been found to cause the leakage of pouch contents into the peritoneal cavity, should these devices erode into the gastric pouch. The body is unable to form scar tissue around, and seal off, such a wide band device. This erosion problem is serious in that some deaths have occurred, and in lesser cases, these prior art bands have had to be removed, or else additional surgeries were necessary to repair leakage problems.
  • Second, the adjustable band devices have a tendency to accidentally enlarge, thereby letting more food through the restricted area than desired, and causing weight gain to return.
  • Therefore, a need exists for a gastric bypass band which does not promote leakage of pouch contents into the peritoneal cavity and which further does not accidentally enlarge, thereby allowing weight gain to return.
  • The foregoing reflects the state of the art of which the inventor is aware, and is tendered with a view toward discharging the inventor's acknowledged duty of candor, which may be pertinent to the patentability of the present invention. It is respectfully stipulated, however, that the foregoing discussion does not teach or render obvious, singly or when considered in combination, the inventor's claimed invention.
  • SUMMARY OF THE INVENTION
  • The invention is a method for performing gastric bypass surgery and an inventive gastric bypass band used along with the method.
  • The method of surgery involves separating the esophagus and a portion of the proximal stomach from the top of the remaining major portion of the stomach. The separated portion is used to form a small gastric pouch that can hold between 20-30 cc (about ⅛ cup) of food material. The inventive gastric bypass band is then placed in the mid-portion of the pouch to create a valve-like opening which will cause solid foods to stay in the gastric pouch for awhile, to give the sensation of a “full stomach.” The band also prevents stomal dilation, that is the stoma, or opening between the pouch and small intestine (described further below) is prevented from dilating.
  • Still in reference to the inventive method, the small intestine is bisected to create a top section and a bottom section. Preferably, the top section includes the duodenum which retains all of its capability to receive liver bile, enzymes, and pancreatic secretions. The bottom section is connected to the bottom of the gastric pouch so that any food materials that pass by the gastric band restriction will empty directly into the small intestine for further digestion. The top section is then connected to the bottom section of the intestine which allows liver bile and pancreatic secretions from the top section to come into contact with the partially digested food materials that have been traveling from the gastric pouch down to the bottom section. Liver bile begins fat digestion for the first time and as a result, fats are only partially absorbed, contributing to greater weight loss.
  • The majority portion of the stomach comprising the remaining stomach and duodenum is completely separated from the manufactured digestive tract consisting of the gastric pouch and bottom section of the small intestine. The majority portion is sewed against the inner body cavity wall of the patient, and a radiopaque marker band is placed between the majority portion and the body cavity wall. A gastrostomy tube is placed through the marker band for immediate post operative care and the radiopaque marker band functions as a marker to locate this stomach site if it becomes necessary to place a gastrostomy tube for decompression or to feed the patient normally through the stomach or else to allow the surgery to be reversed and the stomach reconnected at a later date. The inventive gastric bypass band is also radiopaque.
  • The gastric band device which also comprises the invention is comprised of an expansion-resistant section that is attached to a latching mechanism. Preferably, the latching mechanism is of a one-way, male-female design, which comes together from opposite ends of the expansion-resistant section. When the latch is engaged, the band device assumes a radial shape which encircles the gastric pouch at a location selected by the surgeon. The radial shape and small width of the band helps prevent the device from becoming ingrown into the gastric pouch and/or causing tissue necrosis. The radial shape is best achieved if the opposite components of the latch are curved to aid in forming the radial shape upon joining the ends of the latch together.
  • It has been found that over time, using experimental fore runners of the inventive device and method, when employed together, resulted in patients maintaining their weight loss in 90% of the cases that are followed beyond 5 years post-surgery. This, compared with a success rate of only 65% of weight loss beyond 5 years post-surgery for the prior art gastric bypass surgery methods and banding devices, illustrates a large advantage of the inventive device and method.
  • As such, the following objects and advantages are sought to be achieved by the inventive gastric bypass band device and medical method:
  • An object of the invention is to provide a gastric bypass surgical method which bypasses the majority of the stomach and duodenum, thereby resulting in less post-surgery expansion of the gastric pouch.
  • Another object of the invention is to provide a gastric bypass band device which is available in multiple sizings to be able to meet any surgical situation.
  • Still another object of the invention is to provide a medical method and associated gastric band device which results in maintaining a 90% weight loss, beyond 5 years post-surgery, in morbidly obese patients.
  • Another object of the invention is to provide a device that can be easily placed and removed less invasively, laparoscopically, thereby reducing surgical recovery time to around three weeks.
  • Further objects and advantages of the invention will be brought out in the following portions of the specification, wherein the detailed description is for the purpose of fully disclosing preferred embodiments of the invention, without placing limitations thereon.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be more fully understood by reference to the following drawings which are for illustrative purposes only:
  • FIG. 1 is a frontal view of a human esophagus, stomach and partial small intestine to illustrate the body locations near the esophagus and small intestine where the inventive medical procedure is performed.
  • FIG. 2 is a frontal view of a human body cavity showing the esophagus connected to the lower portion of the small intestine and the upper portion of the small intestine, containing the duodenum, being connected to the lower portion of the small intestine.
  • FIG. 3 is an elevated perspective view of the inventive gastric bypass band shown in its engaged state.
  • FIG. 4 is a cross sectional view through the expansion resistant section of the inventive gastric bypass band.
  • FIG. 5A is a closeup elevated perspective view of the female portion of the latch.
  • FIG. 5B is a closeup elevated perspective view of the male portion of the latch.
  • FIG. 5C is a closeup elevated perspective view of the male portion of the latch fully engaged within the female portion.
  • FIG. 6 is a side view of the gastric bypass band device shown in an engaged position, illustrating the radial shape of the device.
  • FIG. 7A is a side view of a protective cover for engaging with the female portion of the gastric bypass band device.
  • FIG. 7B is a front elevated perspective view of the cover.
  • FIG. 8 is an elevated perspective view of the radiopaque marker band of the present invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • Referring to FIGS. 1 and 2, the preferred embodiment of the inventive medical method can be shown. The medical method is performed laparoscopically in 90% of the cases. In FIG. 1, the organs of the esophagus 10, stomach 14, duodenum 16, small intestine 18 and gall bladder 20 are shown. The focus of the medical method is upon the modifications made to the esophagus 10, stomach 14 and small intestine 18. As first shown in FIG. 1, a gastric pouch is manufactured by preferably separating the esophagus 10 and part of the lesser curvature 22 of the stomach from the remainder of the stomach 14 at point A. The small intestine 18 is bisected at point B. The location of point B is preferred because it results in the duodenum 16 being completely bypassed along with the stomach 14. Bypassing the duodenum results in selective fat malabsorption which results in more weight loss than in prior art gastric bypass methods. The duodenum remains fully functional and continues to receive liver bile from the hepatic ducts 24 and enzymes from the pancreatic duct 26.
  • Referring now to FIG. 2, the formation of the gastric pouch and the re-connection of the small intestine can be described. The proximal stomach is bisected on the lesser curvature 22 just below the esophagus 10, leaving a small stomach segment 28 that is connected to the proximal jejunum 18, this esophogeal and small stomach segment is what will eventually form the gastric pouch 30 having a size of between 20-30 cc. The bottom section of the small intestine (proximal jejunum) 18 below the duodenum 16 is connected to the small stomach segment 28 through a hand sewn closure to form an anastomosis (not shown) that is 1.5 to 2 cm wide. The anastomosis is impervious to air and water and allows direct entry of the contents of the gastric pouch 30 into the small intestine 18, which causes the release of satiety stimulating chemicals known as enterokinins. This release of enterokinins is even induced by the obese individual's salivary secretions that go from the gastric pouch 30 to the small intestine 18. This feeling of satiety, or “fullness” results in anorexia and enhances initial weight loss as well as the maintenance of weight loss over time.
  • Above the anastomosis and above the bottom of the pouch 30, about 2 cm, is placed the inventive gastric bypass band device 32. The gastric band device acts as a restrictor valve which controls the emptying of partially digested food materials from the gastric pouch 30. The gastric band 32 is preferably placed at the distal portion of the gastric pouch 30. When the inventive gastric band is in place, the portion of the pouch above the gastric band is 15 to 20 cc in capacity and the portion of the pouch below the band is about 8 to 10 cc in capacity. This compared to the normal 2000-3000 cc capacity of the stomach illustrates the restriction in food intake provided by the gastric pouch. Once the gastric pouch is full of food materials, a feeling of satiation is experienced, resulting in anorexia. The gastric band device 32 preferably ranges in size between 5.5-7.0 cm in inner circumference. In addition to its function as a restrictor valve, the gastric band 32 prevents stomach dilation, meaning that the restricted opening provided by the band never expands in size due to the expansion-resistant construction of the device. Moreover, the pouch 30 is more resistant to expansion than the stomach. The relative size of the pouch ensures that excessive expansion does not occur. Patients that have been X-rayed five years post-surgery show that the pouch has not expanded by much. Moreover, the small size of the pouch insures that if a patient over-eats, the food will back up into the esophagus, thereby causing the patient to regurgitate the food. This factor operates as a self-regulating feature, and for this reason, patients are counseled to keep their food intake to a minimum.
  • The duodenum 16 is re-joined to the small intestine 18 to form a Y-limb 34, with one deviation of the limb going upward to the duodenum and the other deviation proceeding upward to the gastric pouch 30. The intestine-intestine connection 36 forms an anastomosis (not shown) of approximately 2 cm, that is wide enough to allow food to pass through easily. At the point of anastomosis, pancreatic juices and liver bile from the duodenum can now come into contact with the partially digested food that travels down the second section of the intestine from the pouch. Liver bile begins fat digestion for the first time, and as a result, fats are only partially absorbed, thereby helping contribute to weight loss. Sugars are absorbed, but discouraged as part of the patient's diet, because with the stomach disconnected, they go directly into the intestines, causing some patients to have “Dumping Syndrome.” This is a very uncomfortable feeling of cramps, flushing, fast beating heart, weakness and sometimes watery stools.
  • The stomach 14, although disconnected, remains fully functional, and if necessary can be reactivated by reversing the surgery and re-connecting the stomach segment 28 and small intestine 18 to their prior, natural, state. The stomach 14 can also be reactivated by placing a temporary gastrostomy tube 38, as shown, through which food can be routed, should this be necessary. To facilitate the reactivation of the stomach 14, the stomach opening 40 can be marked with a radiopaque marker band 42 or disk, that is sutured to the abdominal wall, thereby making it clearly visible to allow the surgeon to find the stomach entry site 40 on an X-ray, to allow easy reactivation.
  • The inventive gastric bypass band device 32 that was introduced previously, as being crucial to the successful result of the inventive surgical method, will now be described in terms of its preferred embodiment. Referring to FIG. 3, the gastric bypass band 32 is comprised of an expansion-resistant section 44 mated to a latch 46, which locks upon full engagement, thereby preventing the device 32 from opening up while positioned within the body. The latch 46 is of a one-way variety and can only be released through the application of a specialized surgical tool (not shown). The expansion-resistant section 44 prevents the device from expanding too far, thereby restricting the amount of food traveling from the gastric pouch 30 to the small intestine 18. It is important for the device to retain food within the pouch long enough for the patient to feel sated, thereby reducing hunger and preventing further eating. The expansion-resistant section 44 is preferably made from implant grade silicone rubber surrounding a monofilament core. The monofilament can be polypropylene suture material, which is resistant to expansion. The latch is preferably made from surgical-grade plastics such as polypropylene or acetal, which gives both strength and lubricity to the latch.
  • FIG. 4 shows a transverse cross section of the expansion-resistant section 44 which illustrates the monofilament core 48 surrounded by silicone material 50. Alternatively, the silicone material can be a silicone tube having a monofilament core therein. The expansion-resistant section 44 preferably has a flat-faced inner side 52 as shown. This flat face 52 continues longitudinally along the length of the expansion-resistant section 44. The flat face 52 forms a flat-sided inner circumference when the latch of the device is engaged, as shown in FIG. 3. It has been found that the flat face prevents the expansion-resistant section from migrating into the patient's tissue and prevents tissue erosion. Also crucial with regard to preventing leakage caused by the device eroding into the internal lumen of the gastric pouch is that the cross-sectional diameter of the expansion-resistant section 44 is kept to 0.125″, or less. If erosion occurs, it has been found that if the cross section is kept to these approximate dimensions the pouch tissue will form a scar around the band device 32, and in essence seal off the device, thereby preventing any leakage.
  • Erosion is caused by tissue necrosis, where tissue dies when the supply of blood to the area is cut off. Prior art larger, thicker, band devices, have been known to necrose when the food pouch begins to sag, making a deep sack out of which food has difficulty being passed. This food begins to decay in the pouch, which can lead to necrotic complications. The larger, thicker, prior art devices penetrate the necrosed area in time, creating a break in the gastric pouch, which can lead to leakage of the pouch contents into the interior of the body cavity. In the worst cases this can lead to death; in the minor cases, additional surgery is necessary to repair the breached pouch. Contrastingly, fewer pouch breaches are experienced with the present invention than with the prior art devices.
  • Referring now to FIGS. 5A, 5B and 5C the latch 46 can be examined. The latch is preferably a one-way latch employing a one-way male-female engagement. The opposite ends 54, 56 of the expansion-resistant section 44 are each mated to one-half of the male-female latch as shown in FIG. 3 and a preferred method of mating is further described below.
  • As shown in FIG. 5A, the female portion 58 of the latch 46 is illustrated in detail. The female portion has an exterior body 60 and an interior lumen 62 for receiving the male portion 64 of the latch. The lumen 62 is sized to compress the lateral prongs 66 of the male portion 64. Under surgical conditions, engagement of the male and female portions is performed with a forceps, laparoscopically. The preferred interior lumen 62 dimensions are approximately height=0.082″×width=0.190×length=0.300″. A pair of openings 68 are placed in each side 70 of the female portion 58 to allow for the expansion of the lateral catches 72 of the male portion.64. The lateral catches 72 engage fully and laterally within the side openings 68, in a one-way fashion. Side openings 68 have top, bottom, rear and front walls, which engage catches 72. The engagement is such that the latch can be released only after applying a special surgical tool (not shown) to disengage the latch 46, by placing inward force upon catches 72 through side openings 68. The lumen 62 opens outward and the face 74 of the opening of the lumen is inwardly beveled so as to receive the outward bevels 76 of the male portion 64. The corner facings 78 of the female portion 58 are rounded so as to present a non-irritating surface to the patient.
  • Still referring to FIG. 5A, the body 60 of the female portion 58 is longitudinally curved 80. The curvature of the female portion 58 mates with the longitudinally curved male portion 64 to form the device 32 into a radial shape as shown in FIG. 6. This radial shape is crucial for preventing the device from becoming ingrown within a patient's tissue, as this shape applies equal pressure to the enclosed tissue at every point along the inside circumference of the device 32. Shapes that are non-circular (e.g. oblong shapes) tend to apply unequal pressure along their inside circumference, thereby resulting in a cutoff of blood supply, necrosis, and eventual tissue erosion and leakage as discussed previously. For each graduation in inner circumference of the inventive device 32, a corresponding radius of curvature applies which contributes to the forming of the proper radial shape in each case. The radii of curvature in inches is listed after each graduation in inner circumference (centimeters) as follows: 5.5 cm=0.398″; 6.0 cm=0.422″; 6.5 cm=0.460″ and 7.0 cm=0.492″. Also, for the same graduations, the following diameters apply: 5.5 cm=1.75 cm dia; 6.0 cm=1.91 cm dia; 6.5 cm=2.07 cm dia; 7.0 cm=2.23 cm dia. The inner circumference that is used is open to the discretion of the surgeon, but generally, men require 6.5 and 7.0 cm sizes while women require 5.5 and 6.0 cm devices.
  • Referring now to FIG. 5B, the male portion of the latch is shown as comprising a pair of lateral prongs 66, the prongs being longitudinally curved to mate efficiently within the lumen 62 of the female portion 58. Preferably, prongs 66 are approximately 0.076″ thick, by 0.040″ wide. The prongs terminate at their front with lateral catches 72 which are molded integrally with the prongs 66. Lateral catches 72 are angled longitudinally along their side face 84, the angled attitude allowing easy entry of the prongs 66 into the lumen 62 of the female portion 58, which is an important feature under surgical conditions. Side faces 84 having steeper angles give a mechanical advantage when locking. The preferred angle of side faces is 36 degrees or less. The catches 72 further comprise lateral catch faces 86, which engage the front walls of the side openings 68 of the female portion 58. When the catches 72 of prongs engage, it is preferred that they remain engaged under a pulling stress of at least 5 pounds of force. The prongs 66 are separated by inner space 88, which allows the prongs to travel inward and outward. The prongs 66 terminate rearwardly at prong body 90, which provides a base of structural integrity from which prongs can confidently travel inward and outward as they engage the interior walls of lumen. Prong body 90 migrates further rearward to become outwardly beveled face 76 which mates with inwardly beveled face 74 of the female portion 58. The beveled face 76 migrates further rearward to become hilt 92. Hilt 92 is where the front opening of the female portion 58 fully engages against. This engagement is shown in FIG. 5C which illustrates lateral catches 72 seated in the side openings 68 of female portion 58, the hilt being 92 engaged with the front opening of female portion. The circumference of the body 60 of female portion 58 and the circumference of the hilt 92 of the male portion 64 are preferably identical so as to provide a fairly uninterrupted surface traveling from one to the other.
  • Also shown in FIGS. 5A and 5B are anchor arms 94, which are used to attach the male and female portions of latch to the expansion-resistant section 44. Anchor arms 94 retain the curved theme of the male and female portions, 58, 64 of the latch 46. Anchor arms 94 are molded integrally with their corresponding latch portion and curve rearwardly so as to retain the radii of curvature of the inventive device noted previously. The expansion-resistant section which is comprised of surgical grade silicone and monofilament is attached to the anchor arms as follows. Referring again to FIG. 5B, the front opening 96 of lumen 98 is shown, and its rearward path of travel through anchor arm is shown in phantom. A similar arrangement exists for female portion. Monofilament 48 enters the rear of anchor arm and is fed through lumen until it protrudes through the front opening of lumen. The monofilament 48 is then tied off in a manner so as to anchor it in place along with the silicone material as seen in phantom, in FIG. 3.
  • As FIGS. 7A-7B show, the body 60 of female portion 58 may also be fitted with a disposable cover 100 so as to reduce its potential to snag upon tissue as it is being fed through and positioned around the gastric pouch 30 during laparoscopic surgery. As the device is fed through the tissue and around the new pouch, it is led by the female portion 58. Cover 100 provides a streamlined shape which can be grasped by a forceps and easily led through the tissue. FIG. 7A is a side view showing the female end 58 positioned in the cover 100, with the remainder of the device trailing out the back end 102 of cover 100. Back end 102 of cover includes a lumen (see FIG. 7B) 104 for receiving female end 58, the lumen being sized to snugly grasp female end without coming loose during surgical placement. The sides of lumen are preferably ringed with small ridges 106 to reduce the frictional engagement between female portion 58 and the cover 100 to a level that allows easy removal of the cover once the device is in place. As seen in FIG. 7B, cover 100 further comprises a blunt front end 108 which extends into an elongate portion 110. The blunt front end 108 facilitates easy movement through tissue. The elongate portion 110 is for grasping by the surgeon's forceps to allow the cover to be threaded through tissue. Past the elongate portion 110, the cover 100 has a gently tapered region 112, which, again contributes to easy movement through tissue. At its widest point, the cover is about 0.250 to allow easy movement through a trocar during laparoscopic surgery. The cover is preferably made from a radiopaque material for easy sighting on an X-ray. The cover is removed and discarded once the device has been positioned around the gastric pouch.
  • Referring now to FIG. 8, the radiopaque marker band 42 previously shown in FIG. 2 can be more precisely described. The band's inside diameter is approximately 0.8″ and the outside diameter is approximately 1″ with a thickness of approximately 0.06″. The band is preferably flat along its major surfaces 114, 116. The marker band 42 can be made from polyester mesh that is coated with surgical grade silicone. Also, it is envisioned by the inventor that the inventive device 32 can be combined with the radiopaque marker band 42 shown in FIG. 8, as well as with the disposable cover 100 to form a surgical kit. This kit can then be installed surgically using the method previously described.
  • Finally, although the description above contains many specificities, these should not be construed as limiting the scope of the invention but as merely providing illustrations of some of the presently preferred embodiments of this invention. Other modifications by those skilled in this art are possible and are included within the scope of the appended claims.

Claims (9)

What is claimed is:
1. A surgical band device that is laparoscopically implantable within a patient's body, comprising:
a flexible expansion-resistant section having first and second ends, the expansion-resistant section having a flat face extending along its length between the first and second ends, the expansion-resistant section being of uniform-cross section between the first and second ends; and
a lockable latch having a longitudinal curvature and first and second latch parts coupled to the first and second ends of the expansion-resistant section; wherein the expansion-resistant section having a longitudinally extending configuration along its length when the first and second latch parts are unlocked and the surgical band device is fed laparoscopically through tissue within the patient's body and a radial shape configuration along its length when the first and second latch parts are locked and the surgical band device is positioned around tissue within the patient's body;
wherein the first and second latch parts of said lockable latch are engaged by a male-female type engagement;
wherein the first latch part of the lockable latch including an exterior body having an interior lumen, said exterior body having side through-openings communicating with said lumen, said lumen including a front opening;
wherein the second latch part of the lockable latch including prongs extending from a prong body, said prongs extending forward of said prong body and having two lateral catches, said lateral catches including angled side faces for engaging in a lockable one-way engagement with said side openings of said second latch part when said first and second latch parts are fully engaged.
2. The band device as recited in claim 1, wherein the expansion-resistant section comprises a length of silicone having a monofilament core.
3. The band device as recited in claim 2, wherein the monofilament core is a polypropylene suture.
4. The band device as recited in claim 3, wherein the device is radiopaque.
5. The band device as recited in claim 1, wherein the latch locks in a one-way engagement.
6. A surgical kit, comprising:
a gastric bypass band device that is laparoscopically implantable within a patient's body, comprising:
a flexible expansion-resistant section having first and second ends, the expansion-resistant section having a flat face extending along its length between the first and second ends, the expansion-resistant section being of uniform-cross section between the first and second ends; and
a longitudinal curved lockable latch having first and second latch parts coupled to the first and second ends of the expansion-resistant section; and wherein the expansion-resistant section having a longitudinally extending configuration along its length when the first and second latch parts are unlocked and the surgical band device is fed laparoscopically through tissue within the patient's body and a radial shape configuration along its length when the first and second latch parts are locked and the surgical band device is positioned around tissue within the patient's body;
a radiopaque marker band; and
a disposable positioner cover fitted over the second latch part and having a blunt forward profile for guiding the gastric band device into position about tissue in a patient's body.
7. The surgical kit as recited in claim 6, wherein the band device, and the disposable cover are radiopaque.
8. The surgical kit as recited in claim 6, wherein the positioner cover further comprises a lumen for receiving the second latch part, the lumen of the positioner cover being lined with longitudinal ridges.
9. The cover as recited in claim 8, wherein the lumen forms a rear opening in the positioner cover, the lumen portion extending forward and mating with an elongate portion of the positioner cover, the elongate portion terminating in a blunt forward end.
US13/767,354 2004-05-26 2013-02-14 Gastric bypass band and surgical method Abandoned US20140051914A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13/767,354 US20140051914A1 (en) 2004-05-26 2013-02-14 Gastric bypass band and surgical method
US15/170,831 US20170020705A1 (en) 2004-05-26 2016-06-01 Gastric bypass band and surgical method

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57474104P 2004-05-26 2004-05-26
US10/876,397 US7909839B2 (en) 2004-05-26 2004-06-24 Gastric bypass band and surgical method
US13/053,018 US8469978B2 (en) 2004-05-26 2011-03-21 Gastric bypass band and surgical method
US13/767,354 US20140051914A1 (en) 2004-05-26 2013-02-14 Gastric bypass band and surgical method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/053,018 Continuation US8469978B2 (en) 2004-05-26 2011-03-21 Gastric bypass band and surgical method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/170,831 Continuation US20170020705A1 (en) 2004-05-26 2016-06-01 Gastric bypass band and surgical method

Publications (1)

Publication Number Publication Date
US20140051914A1 true US20140051914A1 (en) 2014-02-20

Family

ID=35461490

Family Applications (4)

Application Number Title Priority Date Filing Date
US10/876,397 Expired - Fee Related US7909839B2 (en) 2004-05-26 2004-06-24 Gastric bypass band and surgical method
US13/053,018 Expired - Fee Related US8469978B2 (en) 2004-05-26 2011-03-21 Gastric bypass band and surgical method
US13/767,354 Abandoned US20140051914A1 (en) 2004-05-26 2013-02-14 Gastric bypass band and surgical method
US15/170,831 Abandoned US20170020705A1 (en) 2004-05-26 2016-06-01 Gastric bypass band and surgical method

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/876,397 Expired - Fee Related US7909839B2 (en) 2004-05-26 2004-06-24 Gastric bypass band and surgical method
US13/053,018 Expired - Fee Related US8469978B2 (en) 2004-05-26 2011-03-21 Gastric bypass band and surgical method

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/170,831 Abandoned US20170020705A1 (en) 2004-05-26 2016-06-01 Gastric bypass band and surgical method

Country Status (4)

Country Link
US (4) US7909839B2 (en)
EP (1) EP1778098B1 (en)
BR (1) BRPI0511502A (en)
WO (1) WO2005117716A2 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110087250A1 (en) * 2008-04-14 2011-04-14 Compagnie Europeenne d'Etude et de Recherche de Recherhe de Dispositifs pour I'lmplantation par La Gastric ring with switching pockets
US10349982B2 (en) 2011-11-01 2019-07-16 Nuvasive Specialized Orthopedics, Inc. Adjustable magnetic devices and methods of using same
US10478232B2 (en) 2009-04-29 2019-11-19 Nuvasive Specialized Orthopedics, Inc. Interspinous process device and method
US10617453B2 (en) 2015-10-16 2020-04-14 Nuvasive Specialized Orthopedics, Inc. Adjustable devices for treating arthritis of the knee
US10646262B2 (en) 2011-02-14 2020-05-12 Nuvasive Specialized Orthopedics, Inc. System and method for altering rotational alignment of bone sections
US10660675B2 (en) 2010-06-30 2020-05-26 Nuvasive Specialized Orthopedics, Inc. External adjustment device for distraction device
US10729470B2 (en) 2008-11-10 2020-08-04 Nuvasive Specialized Orthopedics, Inc. External adjustment device for distraction device
US10743794B2 (en) 2011-10-04 2020-08-18 Nuvasive Specialized Orthopedics, Inc. Devices and methods for non-invasive implant length sensing
US10751094B2 (en) 2013-10-10 2020-08-25 Nuvasive Specialized Orthopedics, Inc. Adjustable spinal implant
US10835290B2 (en) 2015-12-10 2020-11-17 Nuvasive Specialized Orthopedics, Inc. External adjustment device for distraction device
US10918425B2 (en) 2016-01-28 2021-02-16 Nuvasive Specialized Orthopedics, Inc. System and methods for bone transport
US11191579B2 (en) 2012-10-29 2021-12-07 Nuvasive Specialized Orthopedics, Inc. Adjustable devices for treating arthritis of the knee
US11202707B2 (en) 2008-03-25 2021-12-21 Nuvasive Specialized Orthopedics, Inc. Adjustable implant system
USD942028S1 (en) * 2021-04-19 2022-01-25 Shenzhen Fulinyun Technology Co., Ltd. Weight reducing apparatus
US11234849B2 (en) 2006-10-20 2022-02-01 Nuvasive Specialized Orthopedics, Inc. Adjustable implant and method of use
US11246694B2 (en) 2014-04-28 2022-02-15 Nuvasive Specialized Orthopedics, Inc. System for informational magnetic feedback in adjustable implants
US11357549B2 (en) 2004-07-02 2022-06-14 Nuvasive Specialized Orthopedics, Inc. Expandable rod system to treat scoliosis and method of using the same
US11439449B2 (en) 2014-12-26 2022-09-13 Nuvasive Specialized Orthopedics, Inc. Systems and methods for distraction
US11612416B2 (en) 2015-02-19 2023-03-28 Nuvasive Specialized Orthopedics, Inc. Systems and methods for vertebral adjustment

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211114B2 (en) * 2002-08-26 2007-05-01 The Trustees Of Columbia University In The City Of New York Endoscopic gastric bypass
US7901419B2 (en) * 2002-09-04 2011-03-08 Allergan, Inc. Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use
BR0316956A (en) 2002-12-02 2005-10-25 Gi Dynamics Inc Gastrointestinal implant device; treatment method; method of treating type 2 diabetes; delivery system for placing a gastrointestinal implant device in a body; removal device for removing a gastrointestinal implant device from the body; and delivery appliance
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US7766973B2 (en) 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
JP4512597B2 (en) 2003-12-09 2010-07-28 ジーアイ・ダイナミックス・インコーポレーテッド Device fixed in gastrointestinal tract and fixing method
US7909839B2 (en) * 2004-05-26 2011-03-22 Bariatec Corporation Gastric bypass band and surgical method
EP1799145B1 (en) 2004-09-17 2016-12-21 GI Dynamics, Inc. Gastrointestinal anchor
US7771382B2 (en) 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
US20060244291A1 (en) * 2005-04-29 2006-11-02 Buell Motorcycle Company Movable tailrack for a motorcycle
US9345604B2 (en) * 2005-05-02 2016-05-24 Almuhannad Alfrhan Percutaneous intragastric balloon device and method
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
US7416528B2 (en) 2005-07-15 2008-08-26 Ethicon Endo-Surgery, Inc. Latching device for gastric band
US8182411B2 (en) * 2005-07-15 2012-05-22 Ethicon Endo-Surgery, Inc. Gastric band with mating end profiles
US20070015955A1 (en) * 2005-07-15 2007-01-18 Mark Tsonton Accordion-like gastric band
US8298133B2 (en) * 2005-07-15 2012-10-30 Ethicon Endo-Surgery, Inc. Gastric band composed of different hardness materials
US7364542B2 (en) * 2005-07-15 2008-04-29 Ethicon Endo-Surgery, Inc. Gastric band suture tab extender
US7367937B2 (en) * 2005-07-15 2008-05-06 Ethicon Endo-Surgey, Inc. Gastric band
US7615001B2 (en) * 2005-07-15 2009-11-10 Ethicon Endo-Surgery, Inc. Precurved gastric band
US7618365B2 (en) * 2005-07-15 2009-11-17 Ethicon Endo-Surgery, Inc. Method of implating a medical device using a suture tab extender
US7908700B2 (en) * 2006-02-28 2011-03-22 Dipippo Joe J Self-cleaning hair brush
US20080228126A1 (en) * 2006-03-23 2008-09-18 The Trustees Of Columbia University In The City Of New York Method of inhibiting disruption of the healing process in a physically modified stomach
US7763039B2 (en) * 2006-06-09 2010-07-27 Ethicon Endo-Surgery, Inc. Articulating blunt dissector/gastric band application device
US7819836B2 (en) 2006-06-23 2010-10-26 Gi Dynamics, Inc. Resistive anti-obesity devices
US8246533B2 (en) 2006-10-20 2012-08-21 Ellipse Technologies, Inc. Implant system with resonant-driven actuator
US8801647B2 (en) 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
US20080255460A1 (en) * 2007-04-13 2008-10-16 Ethicon Endo-Surgery, Inc. Nanoparticle tissue based identification and illumination
US8092474B2 (en) * 2007-05-21 2012-01-10 Ethicon Endo-Surgery, Inc. Methods and devices for placement of an intra-abdominal or intra-thoracic appliance through a natural body orifice
US8057472B2 (en) 2007-10-30 2011-11-15 Ellipse Technologies, Inc. Skeletal manipulation method
WO2009132076A2 (en) * 2008-04-22 2009-10-29 Ethicon Endo-Surgery, Inc. Methods and devices for providing direction to surgical tools
FR2941366B1 (en) * 2009-01-28 2011-02-25 Cie Euro Etude Rech Paroscopie GASTRIC RING WITH ROD
US8197490B2 (en) 2009-02-23 2012-06-12 Ellipse Technologies, Inc. Non-invasive adjustable distraction system
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US8702641B2 (en) 2009-04-03 2014-04-22 Metamodix, Inc. Gastrointestinal prostheses having partial bypass configurations
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
BRPI1014701B8 (en) 2009-04-03 2021-06-22 Metamodix Inc modular system to treat metabolic disorders such as diabetes and obesity
IN2012DN00316A (en) 2009-07-10 2015-05-08 Metamodix Inc
US8702728B2 (en) 2010-03-12 2014-04-22 No-Bull Enterprises Llc Method and system for ligating a body part
WO2012021378A2 (en) 2010-08-09 2012-02-16 Ellipse Technologies, Inc. Maintenance feature in magnetic implant
EP2468218B1 (en) 2010-12-23 2013-07-03 Q Medical International AG Medical restriction device for hollow organs of a body
US9456916B2 (en) 2013-03-12 2016-10-04 Medibotics Llc Device for selectively reducing absorption of unhealthy food
US10159699B2 (en) 2013-01-15 2018-12-25 Metamodix, Inc. System and method for affecting intestinal microbial flora
ITMO20130034A1 (en) * 2013-02-14 2014-08-15 Thd Spa DEVICE FOR ANAL RIM AND METHOD FOR RESTORING THE SPINTERIAL TONE.
US8899979B2 (en) * 2013-02-28 2014-12-02 Garrison Dental Solutions Matrix ring for tooth restoration
US9067070B2 (en) 2013-03-12 2015-06-30 Medibotics Llc Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type
US9011365B2 (en) 2013-03-12 2015-04-21 Medibotics Llc Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food
FR3011734B1 (en) * 2013-10-16 2015-12-18 Medical Innovation Dev GASTRIC BAND OF CALIBRATION
WO2016205834A1 (en) * 2015-06-19 2016-12-22 Mathias Asongwe Lawrence Fobi Multi-size gastric bypass band and surgical method
USD811593S1 (en) * 2016-02-03 2018-02-27 No-Bull Enterprises, LLC Ligation device
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
EP3457998A4 (en) 2016-05-19 2020-07-29 Metamodix, Inc. Pyloric anchor retrieval tools and methods
USD822213S1 (en) 2017-06-13 2018-07-03 Garrison Dental Solutions, Llc Dental ring
CN109106455B (en) * 2018-08-15 2020-09-04 南京市妇幼保健院 Medical wrist strap and adjustable medical wrist strap lock catch thereof
USD998148S1 (en) * 2021-09-24 2023-09-05 Vivo Surgical Private Limited Surgical loop

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515363A (en) * 1968-05-06 1970-06-02 Illinois Tool Works Spring clip
US4592339A (en) * 1985-06-12 1986-06-03 Mentor Corporation Gastric banding device
US4958791A (en) * 1986-09-17 1990-09-25 Shinagawa Shoko Co., Ltd. Tying means
US5601604A (en) * 1993-05-27 1997-02-11 Inamed Development Co. Universal gastric band
US20040267293A1 (en) * 2003-06-27 2004-12-30 Byrum Randal T. Implantable band with attachment mechanism
US20050038458A1 (en) * 2002-01-09 2005-02-17 Pierre Bailly Gastric ring for treatment of obesity
US20050251181A1 (en) * 2002-09-04 2005-11-10 Bachmann Michel A Closure system for surgical ring
US7828813B2 (en) * 2001-06-01 2010-11-09 Surgical-Ioc Gastric band
US7909839B2 (en) * 2004-05-26 2011-03-22 Bariatec Corporation Gastric bypass band and surgical method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875928A (en) * 1973-08-16 1975-04-08 Angelchik Jean P Method for maintaining the reduction of a sliding esophageal hiatal hernia
IL67773A (en) * 1983-01-28 1985-02-28 Antebi E Tie for tying live tissue and an instrument for performing said tying operation
US5316543A (en) * 1990-11-27 1994-05-31 Cook Incorporated Medical apparatus and methods for treating sliding hiatal hernias
EP0769282B1 (en) 1995-09-22 2000-05-03 Kirk Promotions Limited Device for reducing the food intake of a patient
IL129032A (en) 1999-03-17 2006-12-31 Moshe Dudai Gastric band
US6432040B1 (en) 2000-09-14 2002-08-13 Nizam N. Meah Implantable esophageal sphincter apparatus for gastroesophageal reflux disease and method
US6572627B2 (en) 2001-01-08 2003-06-03 Shlomo Gabbay System to inhibit and/or control expansion of anatomical features
US6843253B2 (en) * 2002-12-11 2005-01-18 C&L Medical Supply Corporation Urinary-control device
US7144400B2 (en) * 2003-10-01 2006-12-05 Ethicon Endo-Surgery, Inc. Gastric band introduction device

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515363A (en) * 1968-05-06 1970-06-02 Illinois Tool Works Spring clip
US4592339A (en) * 1985-06-12 1986-06-03 Mentor Corporation Gastric banding device
US4958791A (en) * 1986-09-17 1990-09-25 Shinagawa Shoko Co., Ltd. Tying means
US5601604A (en) * 1993-05-27 1997-02-11 Inamed Development Co. Universal gastric band
US7828813B2 (en) * 2001-06-01 2010-11-09 Surgical-Ioc Gastric band
US20050038458A1 (en) * 2002-01-09 2005-02-17 Pierre Bailly Gastric ring for treatment of obesity
US20050251181A1 (en) * 2002-09-04 2005-11-10 Bachmann Michel A Closure system for surgical ring
US20040267293A1 (en) * 2003-06-27 2004-12-30 Byrum Randal T. Implantable band with attachment mechanism
US7500944B2 (en) * 2003-06-27 2009-03-10 Ethicon Endo-Surgery, Inc. Implantable band with attachment mechanism
US7909839B2 (en) * 2004-05-26 2011-03-22 Bariatec Corporation Gastric bypass band and surgical method
US8469978B2 (en) * 2004-05-26 2013-06-25 Bariatec Corporation Gastric bypass band and surgical method

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11357549B2 (en) 2004-07-02 2022-06-14 Nuvasive Specialized Orthopedics, Inc. Expandable rod system to treat scoliosis and method of using the same
US11234849B2 (en) 2006-10-20 2022-02-01 Nuvasive Specialized Orthopedics, Inc. Adjustable implant and method of use
US11672684B2 (en) 2006-10-20 2023-06-13 Nuvasive Specialized Orthopedics, Inc. Adjustable implant and method of use
US11202707B2 (en) 2008-03-25 2021-12-21 Nuvasive Specialized Orthopedics, Inc. Adjustable implant system
US20110087250A1 (en) * 2008-04-14 2011-04-14 Compagnie Europeenne d'Etude et de Recherche de Recherhe de Dispositifs pour I'lmplantation par La Gastric ring with switching pockets
US10729470B2 (en) 2008-11-10 2020-08-04 Nuvasive Specialized Orthopedics, Inc. External adjustment device for distraction device
US10478232B2 (en) 2009-04-29 2019-11-19 Nuvasive Specialized Orthopedics, Inc. Interspinous process device and method
US10660675B2 (en) 2010-06-30 2020-05-26 Nuvasive Specialized Orthopedics, Inc. External adjustment device for distraction device
US10646262B2 (en) 2011-02-14 2020-05-12 Nuvasive Specialized Orthopedics, Inc. System and method for altering rotational alignment of bone sections
US10743794B2 (en) 2011-10-04 2020-08-18 Nuvasive Specialized Orthopedics, Inc. Devices and methods for non-invasive implant length sensing
US10349982B2 (en) 2011-11-01 2019-07-16 Nuvasive Specialized Orthopedics, Inc. Adjustable magnetic devices and methods of using same
US11123107B2 (en) 2011-11-01 2021-09-21 Nuvasive Specialized Orthopedics, Inc. Adjustable magnetic devices and methods of using same
US11213330B2 (en) 2012-10-29 2022-01-04 Nuvasive Specialized Orthopedics, Inc. Adjustable devices for treating arthritis of the knee
US11191579B2 (en) 2012-10-29 2021-12-07 Nuvasive Specialized Orthopedics, Inc. Adjustable devices for treating arthritis of the knee
US10751094B2 (en) 2013-10-10 2020-08-25 Nuvasive Specialized Orthopedics, Inc. Adjustable spinal implant
US11246694B2 (en) 2014-04-28 2022-02-15 Nuvasive Specialized Orthopedics, Inc. System for informational magnetic feedback in adjustable implants
US11439449B2 (en) 2014-12-26 2022-09-13 Nuvasive Specialized Orthopedics, Inc. Systems and methods for distraction
US12076051B2 (en) 2015-02-19 2024-09-03 Nuvasive Specialized Orthopedics, Inc. Systems and methods for vertebral adjustment
US11612416B2 (en) 2015-02-19 2023-03-28 Nuvasive Specialized Orthopedics, Inc. Systems and methods for vertebral adjustment
US10617453B2 (en) 2015-10-16 2020-04-14 Nuvasive Specialized Orthopedics, Inc. Adjustable devices for treating arthritis of the knee
US10835290B2 (en) 2015-12-10 2020-11-17 Nuvasive Specialized Orthopedics, Inc. External adjustment device for distraction device
US10918425B2 (en) 2016-01-28 2021-02-16 Nuvasive Specialized Orthopedics, Inc. System and methods for bone transport
USD942028S1 (en) * 2021-04-19 2022-01-25 Shenzhen Fulinyun Technology Co., Ltd. Weight reducing apparatus

Also Published As

Publication number Publication date
US20050277963A1 (en) 2005-12-15
EP1778098B1 (en) 2014-10-29
US20170020705A1 (en) 2017-01-26
US8469978B2 (en) 2013-06-25
BRPI0511502A (en) 2008-01-08
WO2005117716A2 (en) 2005-12-15
EP1778098A4 (en) 2009-12-09
US20110208216A1 (en) 2011-08-25
WO2005117716A3 (en) 2006-11-16
EP1778098A2 (en) 2007-05-02
US7909839B2 (en) 2011-03-22

Similar Documents

Publication Publication Date Title
US20170020705A1 (en) Gastric bypass band and surgical method
US7037344B2 (en) Apparatus and methods for treatment of morbid obesity
US9839546B2 (en) Apparatus and methods for treatment of morbid obesity
US8506516B2 (en) Devices, systems, and methods for achieving magnetic gastric bypass
US8114045B2 (en) Apparatus and methods for delaying gastric emptying to treat obesity
EP1555970B1 (en) Apparatus for treatment of morbid obesity
US8403877B2 (en) Systems and methods for treatment of obesity and type 2 diabetes
US20080221597A1 (en) Methods and devices for intragastrointestinal fixation
US20160206460A1 (en) Systems and methods for treatment of obesity and type 2 diabetes
US20080249533A1 (en) Medical Device and Method For Controlling Obesity
US10568755B2 (en) Gastrointestinal device
JP2008541854A (en) Restricted and / or occluded implant system for promoting weight loss
US20110000496A1 (en) Systems and Mehtods for Treating Obesity and Type 2 Diabetes
WO2013026473A1 (en) Devices and methods for anchoring an endoluminal sleeve in the gi tract
US9295574B2 (en) Systems and methods for treating obesity and type 2 diabetes
US8911392B2 (en) Systems and methods for treatment of obesity and type 2 diabetes
EP3597156A1 (en) Gastrointestinal implant and method for deploying the same

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE